In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bayer, Boehringer Ingelheim to co-market telmisartan

Executive Summary

Bayer AG's pharmaceutical division and Boehringer Ingelheim signed an agreement to co-market BI's antihypertension drug Micardis (telmisartan) and combination product MicardisPlus in Germany, Scandinavia, and Switzerland.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing

Related Companies